MEG Versus EEG HR for the Localization of the Epileptogenic Zone as Part of the Pre-surgical Assessment of Epilepsy

Recruiting N/A Interventional Study
Drug-resistant Epilepsy Candidates for Surgical Treatment Epilepsy
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 – 60
Sex
Any
Study type
Interventional
Purpose
Other
Participants needed
100 (estimated)
Sponsor
Hospices Civils de Lyon · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
Drug-resistant partial epilepsies are disabling diseases for which surgical treatment may be indicated. The determination of the area to be operated (or 'epileptogenic zone') is based on a bundle of clinical arguments and neuroimaging, having a direct impact on surgical success. Epileptic patients have electrical abnormalities that can be detected with surface electrophysiological examinations su…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * patients with partial epilepsy for at least 2 years and for whom are decided and planned: either i) a surgical procedure to resect the epileptogenic zone without prior intracranial EEG recording either ii) an intracranial EEG record needed before a possible cortectomy procedur…
Contacts

Julien JUNG, Dr

04 72 35 79 00

julien.jung@chu-lyon.fr

CONTACT

Camille GIRAUDON

04 26 73 94 38

camille.giraudon@chu-lyon.fr

CONTACT